<DOC>
	<DOCNO>NCT01783574</DOCNO>
	<brief_summary>The investigator ' hypothesis : Low-dose testosterone augmentation improve depressive symptom woman Major Depressive Disorder ( MDD ) antidepressant partial/nonresponse , adjunctive low-dose testosterone safe well-tolerated woman MDD antidepressant partial/nonresponse , low-dose testosterone augmentation improve fatigue sexual dysfunction .</brief_summary>
	<brief_title>Testosterone Antidepressant Augmentation Women</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>1 . Female , age 2175 2 . Major depressive disorder include MADRS &gt; /=12 3 . Currently treat antidepressant monotherapy ( 1st , 2nd 3rd trial current episode ) , take adequate dose least six week . 1 . Serious suicide homicide risk , assess evaluate clinician 2 . Unstable medical illness include cardiovascular , hepatic , renal , respiratory , endocrine , neurologic 3 . Substance use disorder active within last six month , clinical suspicion ongoing substance use disorder discretion study clinician time screen base history and/or laboratory result . 4 . Any history psychotic feature , bipolar disorder , primary obsessive compulsive disorder , assess SCID 5 . Currently treat typical atypical antipsychotic medication , lithium 6 . Untreated hypothyroidism . If treated hypothyroidism , change levothyroxine dose within prior 3 mo 7 . Use androgen , include testosterone , dehydroepiandrosterone ( DHEA ) methyltestosterone , within prior three month 8 . Any investigational psychotropic drug within last thirty day 9 . In judgment study clinician , unlikely able participate safely throughout study period ( three episode selfharm past year , document history poor treatment adherence , frequent miss appointment ( &gt; 50 % ) past year ) 10 . ALT &gt; 3x upper limit normal creatinine &gt; 3x upper limit 11 . History hormoneresponsive cancer</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder ( MDD )</keyword>
</DOC>